Kalargyrou Aikaterini A, Guilfoyle Siobhan E, Smith Alexander J, Ali Robin R, Pearson Rachael A
King's College London, Guy's Hospital, Centre for Gene Therapy and Regenerative Medicine, London, United Kingdom.
Kellogg Eye Center, University of Michigan, Ann Arbor, MI, United States.
Front Mol Neurosci. 2023 Jan 12;15:1042469. doi: 10.3389/fnmol.2022.1042469. eCollection 2022.
The retina encompasses a network of neurons, glia and epithelial and vascular endothelia cells, all coordinating visual function. Traditionally, molecular information exchange in this tissue was thought to be orchestrated by synapses and gap junctions. Recent findings have revealed that many cell types are able to package and share molecular information extracellular vesicles (EVs) and the technological advancements in visualisation and tracking of these delicate nanostructures has shown that the role of EVs in cell communication is pleiotropic. EVs are released under physiological conditions by many cells but they are also released during various disease stages, potentially reflecting the health status of the cells in their cargo. Little is known about the physiological role of EV release in the retina. However, administration of exogenous EVs after injury suggest a neurotrophic role, whilst photoreceptor transplantation in early stages of retina degeneration, EVs may facilitate interactions between photoreceptors and Müller glia cells. In this review, we consider some of the proposed roles for EVs in retinal physiology and discuss current evidence regarding their potential impact on ocular therapies gene or cell replacement strategies and direct intraocular administration in the diseased eye.
视网膜包含一个由神经元、神经胶质细胞、上皮细胞和血管内皮细胞组成的网络,所有这些细胞共同协调视觉功能。传统上,人们认为该组织中的分子信息交换是由突触和缝隙连接协调的。最近的研究发现,许多细胞类型能够通过细胞外囊泡(EVs)包装和共享分子信息,并且在这些精细纳米结构的可视化和追踪方面的技术进步表明,EVs在细胞通讯中的作用是多效性的。EVs在生理条件下由许多细胞释放,但它们也在各种疾病阶段释放,其内容物可能反映细胞的健康状况。关于视网膜中EV释放的生理作用知之甚少。然而,损伤后给予外源性EVs表明其具有神经营养作用,而在视网膜变性早期进行光感受器移植时,EVs可能促进光感受器与穆勒胶质细胞之间的相互作用。在这篇综述中,我们考虑了EVs在视网膜生理学中的一些假定作用,并讨论了关于它们对眼部治疗(基因或细胞替代策略以及在患病眼中直接眼内给药)潜在影响的现有证据。